Bleeding Ulcer and Erosions Study "BLUE Study" (NCT03367897) | Clinical Trial Compass
CompletedNot Applicable
Bleeding Ulcer and Erosions Study "BLUE Study"
Norway543 participantsStarted 2015-03
Plain-language summary
A prospective study of bleeding peptic ulcers and/or erosions in the upper gastrointestinal tract - risk-medication, presence of Helicobacter pylori, treatment and outcome.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients over 18 years who consent to be enrolled in the study
* Patients with hematemesis and/or melena, anemia or positiv FOBT that during gastroscopy are diagnosed with ulcer and/or erosions of the ventricle and/or duodenum.
* Gastroscopy must be performed within 24 hours of the findings above.
Exclusion Criteria:
* Patients who do not wish to participate or are not competent to give consent.
* Patients that due to language problems or other reasons do not understand the content of the information about the study.
* Patients with erosions without hematemesis, in whom one diagnose possible bleeding source on colonoscopy.
* Patients with malignant ulcer, ulcer simplex or cameron lesions.